PharmEasy to vaccinate 3 crore people in coming months
Amid the rising COVID-19 cases in the second wave, we wanted to contribute our bit in breaking the chain by setting up vaccination camps and centres to facilitate this,” said…
Jubilant Pharma develops a novel oral formulation of Remdesivir.
Jubilant Pharma on Monday announced that it has developed a novel oral formulation of Remdesivir, which, the company said, is likely to ease the capacity constraint that injectable formulation faces…
Prices of Ramdesivir slashed on orders of National Pharma authorities.
The National Pharmaceutical Pricing Authority under the Department of Pharmaceuticals declared change in prices for seven brands of Remdesivir injections of potency 100mg per vial Pharmaceutical companies manufacturing the anti-COVID…
Uttar Pradesh to procure 25000 Rendesivir injections from Ahmedabad.
Uttar Pradesh health officials were on Wednesday sent to Ahmedabad to procure 25,000 Remdesivir injections on Chief Minister Yogi Adityanath’s directions. Remdesivir is considered a key antiviral drug in fight…
Government approved Sputnik-V vaccine in India
The government on Monday approved Sputnik-V, the vaccine against the coronavirus disease (Covid-19) developed by Russia. This is the third vaccine approved by India after Covishield and Covaxin. Dr Reddy’s…
Alembic Pharma’s Rhizen gets approval for oral Cancer drug.
This oral cancer drug was found after 08 years of extensive research. The best part of this drug is that it only attacks bad cells of the body, due to…
Rhizen Pharma gets USFDA approval for phase one clinical trials for COVID-19 drug
New Delhi, Rhizen Pharmaceuticals, an associate company of Alembic Pharmaceuticals, on Wednesday said it has received approval from the US health regulator to commence phase one clinical trials on retroviral…